Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 3/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | UBE2N | P61088 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10963455 | 0.80 | LMNA (0.60) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| SCHEMBL10963461 | 0.78 | LMNA (0.58) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| SCHEMBL10970100 | 0.77 | LMNA (0.64) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| SCHEMBL682803 | 0.75 | SMN1; SMN2 (0.57) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| SCHEMBL7010532 | 0.75 | LMNA (0.69) | LMNASMN1; SMN2RXFP1L3MBTL1POLB | |
| SCHEMBL10967060 | 0.74 | RXFP1 (0.54) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| SCHEMBL684353 | 0.73 | SMN1; SMN2 (0.54) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| Dyphylline SCHEMBL123781 | 0.73 | LMNA (1.00) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| Dyphylline SCHEMBL1816552 | 0.73 | LMNA (1.00) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 | |
| Dyphylline SCHEMBL8192 | 0.73 | LMNA (1.00) | LMNASMN1; SMN2RXFP1L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117028517-A | Hydraulic-mechanical-electric composite transmission device | 江苏大学 | 2023-11-10 | — | — | CN | claimed |
| EP-4233078-B1 | NON-CURABLE SILICONE COMPOSITION COMPRISING CARBON BLACK | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2026-05-06 | — | — | EP | disclosed |
| EP-4684830-A2 | SOLID EXTENDED-RELEASE COMPOSITION COMPRISING BRADYKININ B2-RECEPTOR ANTAGONISTS | Pharvaris GmbH (CH) | 2026-01-28 | — | — | EP | disclosed |
| EP-4499038-B1 | SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS | PHARVARIS GMBH (CH) | 2025-12-03 | — | — | EP | disclosed |
| EP-4499039-B1 | SOLID EXTENDED-RELEASE COMPOSITION COMPRISING BRADYKININ B2-RECEPTOR ANTAGONISTS | PHARVARIS GMBH (CH) | 2025-12-03 | — | — | EP | disclosed |
| EP-3850049-B2 | FUNCTIONAL POLYSILOXANES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2025-11-05 | — | — | EP | disclosed |
| US-12430472-B2 | System for verifying edited image | INVENTEC CORPORATION (TW) | 2025-09-30 | — | — | US | disclosed |
| US-12421422-B2 | Powder bed 3D printing process for producing elastic shaped body composed of silicones, and silicone resin-containing powder suitable for the process | UNIVERSITÄT ROSTOCK (DE) | 2025-09-23 | — | — | US | disclosed |
| US-20250268887-A1 | THERAPEUTIC USES OF BRADYKININ B2-RECEPTOR ANTAGONISTS | PHARVARIS GMBH (CH) | 2025-08-28 | — | — | US | disclosed |
| US-20250228781-A1 | SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS | PHARVARIS GMBH (CH) | 2025-07-17 | — | — | US | disclosed |
| EP-2879808-B1 | PROCESS FOR THE MANUFACTURE OF A MULTILAYER SILICONE STRUCTURE | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2023-07-26 | — | — | EP | disclosed |
| US-11666582-B2 | Medicament for treating cough | NIPPON CHEMIPHAR CO., LTD. (JP) | 2023-06-06 | — | — | US | disclosed |
| US-20230130902-A1 | TEXT GENERATION APPARATUS, TEXT GENERATION LEARNING APPARATUS, TEXT GENERATION METHOD, TEXT GENERATION LEARNING METHOD AND PROGRAM | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| CN-115752662-B | Method and device for verifying consistency of magnetostrictive sensor | 新创碳谷集团有限公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-3850049-B1 | FUNCTIONAL POLYSILOXANES | MOMENTIVE PERFORMANCE MAT GMBH (DE) | 2023-03-08 | — | — | EP | disclosed |
| CN-115752662-A | Method and device for verifying consistency of magnetostrictive sensor | 新创碳谷集团有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20220380760-A1 | DISRUPTING GENOMIC COMPLEX ASSEMBLY IN FUSION GENES | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2022-12-01 | — | — | US | disclosed |
| WO-2022207775-A1 | PROCESS FOR CONTINUOUS HOT MELT GRANULATION OF LOW SOLUBLE PHARMACEUTICALS | MERCK PATENT GMBH (DE) | 2022-10-06 | — | — | WO | disclosed |
| US-11352377-B2 | Process for the production of organohydridochlorosilanes | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2022-06-07 | — | — | US | disclosed |
| WO-2022084434-A1 | NON-CURABLE SILICONE COMPOSITION COMPRISING CARBON BLACK | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2022-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352377-B2 | Process for the production of organohydridochlorosilanes | DDT, PKD1, CDV3 | LMNA 4470/4885SMN1; SMN2 3331/4885RXFP1 4452/4885 |
| US-20250228781-A1 | SOLID COMPOSITION COMPRISING SOLUBILISED BRADYKININ B2-RECEPTOR ANTAGONISTS | BDKRB2, BDKRB1, BRS3 | LMNA 2861/4885SMN1; SMN2 3197/4885RXFP1 83/4885 |
| US-11666582-B2 | Medicament for treating cough | P2RX4, P2RX3, P2RX5 | LMNA 2654/4885SMN1; SMN2 3808/4885RXFP1 408/4885 |
| US-20250268887-A1 | THERAPEUTIC USES OF BRADYKININ B2-RECEPTOR ANTAGONISTS | BDKRB2, BDKRB1, BRS3 | LMNA 1984/4885SMN1; SMN2 2758/4885RXFP1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.